Patents by Inventor Jong Gill

Jong Gill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7400920
    Abstract: Morphological features within electrical cardiac signals are tracked and changes in features are monitored to detect renal failure. The morphological feature may be an interval between corresponding polarization events such as the interval between QRS-complexes and peaks of corresponding T-waves (QTmax interval); the interval between QRS-complexes and ends of corresponding T-waves (QTend interval); or the interval between P-waves and corresponding QRS-complexes (PR interval). The feature may also be the elevation of a cardiac signal segment between corresponding polarization events, such as QRS-complexes and corresponding T-waves (ST segment); a duration of a polarization event, such as a QRS-complex (QRS width); or an amplitude of a polarization event, such as a T-wave (T-wave amplitude).
    Type: Grant
    Filed: August 11, 2005
    Date of Patent: July 15, 2008
    Assignee: Pacesetter, Inc.
    Inventors: Jong Gill, Gene A. Bornzin
  • Publication number: 20080086177
    Abstract: A system and related methods for monitoring cardiac disease. The system includes an implantable medical device having a microcontroller that is configured to measure a pacing latency value for a region of a heart, compare the measured pacing latency value to a previously measured pacing latency value for the region of the heart, and determine a change in an amount of cardiac disease in the region of the heart based on the comparison of the measured pacing latency values.
    Type: Application
    Filed: October 9, 2006
    Publication date: April 10, 2008
    Applicant: PACESETTER, INC.
    Inventors: Xiaoyi Min, Paul A. Levine, Jong Gill
  • Publication number: 20080033499
    Abstract: An implantable cardiac system including an implantable cardiac stimulation device provides a heart activity signal of a heart facilitating measurement of slowly changing electrogram features. The system comprises at least one implantable electrode arrangement that senses cardiac electrical activity and provides an intracardiac electrogram signal, a first high pass filter that filters the electrogram and an equalizer that filters the filtered electrogram signal. The equalizer has a transfer function that is non-decreasing for frequencies up to a lower frequency breakpoint that is less than the upper frequency breakpoint, decreasing for frequencies between the lower frequency breakpoint and the upper frequency breakpoint, and generally flat for frequencies above the upper frequency breakpoint through a bandpass region of interest.
    Type: Application
    Filed: October 12, 2007
    Publication date: February 7, 2008
    Applicant: PACESETTER, INC.
    Inventors: Peter Boileau, Gene Bornzin, Jong Gill
  • Patent number: 7297114
    Abstract: Techniques are described for detecting ischemia, hypoglycemia or hyperglycemia based on intracardiac electrogram (IEGM) signals. Ischemia is detected based on a shortening of the interval between the QRS complex and the end of a T-wave (QTmax), alone or in combination with a change in ST segment elevation. Alternatively, ischemia is detected based on a change in ST segment elevation combined with minimal change in the interval between the QRS complex and the end of the T-wave (QTend). Hypoglycemia is detected based on a change in ST segment elevation along with a lengthening of either QTmax or QTend. Hyperglycemia is detected based on a change in ST segment elevation along with minimal change in QTmax and in QTend. By exploiting QTmax and QTend in combination with ST segment elevation, changes in ST segment elevation caused by hypo/hyperglycemia can be properly distinguished from changes caused by ischemia.
    Type: Grant
    Filed: January 25, 2005
    Date of Patent: November 20, 2007
    Assignee: Pacesetter, Inc.
    Inventors: Jong Gill, Peter Boileau, Rupinder Bharmi, Xiaoyi Min, Joseph J. Florio, Michael Benser, Gene A. Bornzin
  • Patent number: 7289847
    Abstract: An apparatus and method of treating atrial fibrillation (AF) are provided. The apparatus includes means for detecting AF in a heart of a patient, means for classifying the AF as one of a plurality of AF types, means for selecting a therapy for delivery to the heart, from a plurality of therapies, based on AF type, and means for delivering the selected therapy to the heart. The plurality of therapies includes ATP therapy, a hybrid therapy including a combination of ATP therapy and drug therapy, and shock therapy. The method includes sensing an electrogram signal from the heart, analyzing the electrogram signal to detect AF in the heart, classifying the AF as one of a plurality of AF types, selecting a therapy for delivery to the heart, from a plurality of therapies, based on the AF type, and delivering the selected therapy to the heart.
    Type: Grant
    Filed: January 18, 2005
    Date of Patent: October 30, 2007
    Assignee: Pacesetter, Inc.
    Inventors: Jong Gill, Gene A. Bornzin
  • Patent number: 7272436
    Abstract: Techniques are described for detecting ischemia, hypoglycemia or hyperglycemia based on intracardiac electrogram (IEGM) signals. Ischemia is detected based on a shortening of the interval between the QRS complex and the end of a T-wave (QTmax), alone or in combination with a change in ST segment elevation. Alternatively, ischemia is detected based on a change in ST segment elevation combined with minimal change in the interval between the QRS complex and the end of the T-wave (QTend). Hypoglycemia is detected based on a change in ST segment elevation along with a lengthening of either QTmax or QTend. Hyperglycemia is detected based on a change in ST segment elevation along with minimal change in QTmax and in QTend. By exploiting QTmax and QTend in combination with ST segment elevation, changes in ST segment elevation caused by hypo/hyperglycemia can be properly distinguished from changes caused by ischemia.
    Type: Grant
    Filed: January 25, 2005
    Date of Patent: September 18, 2007
    Assignee: Pacesetter, Inc.
    Inventors: Jong Gill, Peter Boileau, Rupinder Bharmi, Xiaoyi Min, Joseph J. Florio, Michael Benser, Gene A. Bornzin
  • Publication number: 20070038138
    Abstract: Morphological features within electrical cardiac signals are tracked and changes in features are monitored to detect renal failure. The morphological feature may be an interval between corresponding polarization events such as the interval between QRS-complexes and peaks of corresponding T-waves (QTmax interval); the interval between QRS-complexes and ends of corresponding T-waves (QTend interval); or the interval between P-waves and corresponding QRS-complexes (PR interval). The feature may also be the elevation of a cardiac signal segment between corresponding polarization events, such as QRS-complexes and corresponding T-waves (ST segment); a duration of a polarization event, such as a QRS-complex (QRS width); or an amplitude of a polarization event, such as a T-wave (T-wave amplitude).
    Type: Application
    Filed: August 11, 2005
    Publication date: February 15, 2007
    Inventors: Jong Gill, Gene Bornzin
  • Publication number: 20070027489
    Abstract: A method and device for evaluating the progression of a patient's condition, which in certain applications can include heart failure, on an ongoing manner which reduces the need for immediate attention from skilled clinicians or expensive diagnostic equipment. The method and device analyze relative timing between electrical and mechanical properties of the heart. Detection of an elongated delay between corresponding electrical and mechanical activity is interpreted as indicating a worsening heart failure condition. The analysis and data corresponding thereto can be stored for further analysis and/or telemetrically communicated to an external device. Therapy provided by the device can be altered based on the evaluation of the patient's condition.
    Type: Application
    Filed: July 28, 2005
    Publication date: February 1, 2007
    Inventors: Jong Gill, Xiaoyi Min
  • Publication number: 20060224190
    Abstract: Techniques are provided for detecting left ventricular end diastolic pressure (LV EDP) using a pressure sensor implanted within the heart of a patient and for detecting and evaluating heart failure and pulmonary edema based on LV EDP. Briefly, the peak of the R-wave of an intracardiac electrogram (IEGM) is used to trigger the measurement of a pressure value within the left ventricle. This pressure value is deemed to be representative of LV EDP. In this manner, LV EDP is easily detected merely by measuring pressure at one point within the heartbeat—thereby eliminating any need to track ventricular pressure throughout the heartbeat. Techniques for detecting and evaluating heart failure and pulmonary edema based on the R-wave triggered LV EDP measurements are also set forth herein.
    Type: Application
    Filed: April 5, 2005
    Publication date: October 5, 2006
    Inventors: Jong Gill, Xiaoyi Min
  • Publication number: 20060167518
    Abstract: Techniques are described for detecting ischemia, hypoglycemia or hyperglycemia based on intracardiac electrogram (IEGM) signals. Ischemia is detected based on a shortening of the interval between the QRS complex and the end of a T-wave (QTmax), alone or in combination with a change in ST segment elevation. Alternatively, ischemia is detected based on a change in ST segment elevation combined with minimal change in the interval between the QRS complex and the end of the T-wave (QTend). Hypoglycemia is detected based on a change in ST segment elevation along with a lengthening of either QTmax or QTend. Hyperglycemia is detected based on a change in ST segment elevation along with minimal change in QTmax and in QTend. By exploiting QTmax and QTend in combination with ST segment elevation, changes in ST segment elevation caused by hypo/hyperglycemia can be properly distinguished from changes caused by ischemia.
    Type: Application
    Filed: January 25, 2005
    Publication date: July 27, 2006
    Inventors: Jong Gill, Peter Boileau, Rupinder Bharmi, Xiaoyi Min, Joseph Florio, Michael Benser, Gene Bornzin
  • Publication number: 20060167517
    Abstract: Techniques are described for detecting ischemia, hypoglycemia or hyperglycemia based on intracardiac electrogram (IEGM) signals. Ischemia is detected based on a shortening of the interval between the QRS complex and the end of a T-wave (QTmax), alone or in combination with a change in ST segment elevation. Alternatively, ischemia is detected based on a change in ST segment elevation combined with minimal change in the interval between the QRS complex and the end of the T-wave (QTend). Hypoglycemia is detected based on a change in ST segment elevation along with a lengthening of either QTmax or QTend. Hyperglycemia is detected based on a change in ST segment elevation along with minimal change in QTmax and in QTend. By exploiting QTmax and QTend in combination with ST segment elevation, changes in ST segment elevation caused by hypo/hyperglycemia can be properly distinguished from changes caused by ischemia.
    Type: Application
    Filed: January 25, 2005
    Publication date: July 27, 2006
    Inventors: Jong Gill, Peter Boileau, Rupinder Bharmi, Xiaoyi Min, Joseph Florio, Michael Benser, Gene Bornzin
  • Publication number: 20060167519
    Abstract: Techniques are described for detecting ischemia, hypoglycemia or hyperglycemia based on intracardiac electrogram (IEGM) signals. Ischemia is detected based on a shortening of the interval between the QRS complex and the end of a T-wave (QTmax), alone or in combination with a change in ST segment elevation. Alternatively, ischemia is detected based on a change in ST segment elevation combined with minimal change in the interval between the QRS complex and the end of the T-wave (QTend). Hypoglycemia is detected based on a change in ST segment elevation along with a lengthening of either QTmax or QTend. Hyperglycemia is detected based on a change in ST segment elevation along with minimal change in QTmax and in QTend. By exploiting QTmax and QTend in combination with ST segment elevation, changes in ST segment elevation caused by hypo/hyperglycemia can be properly distinguished from changes caused by ischemia.
    Type: Application
    Filed: January 25, 2005
    Publication date: July 27, 2006
    Inventors: Jong Gill, Peter Boileau, Rupinder Bharmi, Xiaoyi Min, Joseph Florio, Michael Benser, Gene Bornzin
  • Patent number: 5396836
    Abstract: A juice extractor includes a main body equipped with a motor, a gear box having a first shaft and a second shaft to which torque of the motor is transmitted, a housing having a flange connecting surface at the front of the main body, and a pair of squeezing rollers accommodated by the housing and connected to the second shaft so as to receive torque therefrom. First and second clutch gears are alternatively connected to the first and second shafts by a clutching fork extending into the gear box. A connecting gear is connected to the clutch gears. A threaded portion extending to the front of the gear box from the connecting gear is received in a threaded hole in the housing to enable the housing to be separated from the main body.
    Type: Grant
    Filed: August 6, 1993
    Date of Patent: March 14, 1995
    Inventor: Jong Gill Kim
  • Patent number: 5381730
    Abstract: A juice extractor for extracting juice from raw juice containing materials includes a raw material supply hopper of a housing engaged with a main body. The juice extractor includes a pair of squeezing rollers engaged with each other and mounted in the housing. Each of the rollers includes a helical gear and a screw at its leading end portion. A filter surrounds the leading end portions of the squeezing rollers and a discharge section plate is mounted at the leading end portion of the housing and has a discharge pressure adjusting device. Ring gears made of synthetic resins are mounted at both sides of the helical gear of one of the squeezing rollers whereby an interval between the helical gears of squeezing rollers is maintained. Grooves are formed at both sides of the threads of the helical gears of each of the squeezing rollers at a location beneath the raw juice material supply hopper.
    Type: Grant
    Filed: June 30, 1993
    Date of Patent: January 17, 1995
    Inventor: Jong Gill Kim
  • Patent number: D362597
    Type: Grant
    Filed: May 6, 1994
    Date of Patent: September 26, 1995
    Inventor: Jong Gill Kim
  • Patent number: D376736
    Type: Grant
    Filed: October 25, 1995
    Date of Patent: December 24, 1996
    Inventor: Jong-Gill Kim